Healthcare Sector

BMY

Market Tracker

$60.51
+0.78
(+1.31%)
1:20 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • BMY (Selected)

    Bristol-Myers Squibb Company

BMY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

BMY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BMY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BMY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

BMY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BMY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
04/17/2026 CALL $60.00 8,818 +1,046 +13.46%
04/02/2026 PUT $59.00 1,071 +838 +359.66%
04/02/2026 CALL $61.00 717 +461 +180.08%
09/18/2026 PUT $52.50 1,798 +305 +20.43%
09/18/2026 PUT $55.00 2,508 +303 +13.74%
03/19/2027 PUT $60.00 282 +282
01/15/2027 CALL $43.00 692 -42 -5.72%
06/18/2026 CALL $62.50 6,312 -73 -1.14%
09/18/2026 PUT $50.00 5,377 -223 -3.98%
05/15/2026 CALL $62.50 11,072 -271 -2.39%
04/02/2026 CALL $60.00 3,566 -660 -15.62%
09/18/2026 PUT $40.00 7,001 -1,170 -14.32%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BMY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.07% 64.63M 4.03B
Vanguard 500 Index Fund 2.34% 49.15M 3.06B
Fidelity 500 Index Fund 1.11% 23.31M 1.45B
SPDR S&P 500 ETF Trust 1.09% 23.02M 1.43B
iShares Core S&P 500 ETF 0.90% 18.98M 1.18B
Vanguard Index-Value Index Fund 0.87% 18.37M 1.14B
JP Morgan Equity Income Fund 0.82% 17.35M 1.08B
Select Sector SPDR Fund-Health Care 0.82% 17.27M 1.08B
American Mutual Fund Inc 0.78% 16.49M 1.03B
Vanguard Institutional Index Fund-Institutional Index Fund 0.71% 14.9M 927.91M

BMY News

  • Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

    03/30 05:00 am

    GlobeNewswire Inc.

    Read more
  • What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

    03/24 07:06 am

    The Motley Fool

    Read more
  • Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?

    03/23 04:30 pm

    The Motley Fool

    Read more
  • Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

    03/20 01:57 pm

    Benzinga

    Read more
  • CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

    03/17 10:46 pm

    GlobeNewswire Inc.

    Read more
  • The $3B Biotech With Two Shots On Goal

    03/17 07:07 am

    Benzinga

    Read more
  • 1 ETF That Could Turn $100 Per Month Into $67,380

    03/15 05:05 am

    The Motley Fool

    Read more
  • Want Decades of Passive Income? Buy This Index Fund and Hold It Forever

    03/14 05:14 am

    The Motley Fool

    Read more
  • BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

    03/10 08:40 am

    Benzinga

    Read more
  • Abecma (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

    03/10 05:46 am

    GlobeNewswire Inc.

    Read more
  • Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

    03/09 07:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Top Healthcare Dividend Stocks to Buy and Hold Forever

    03/05 04:30 pm

    The Motley Fool

    Read more
  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • OXB announces date for Capital Markets Day and participation in upcoming investor conferences

    03/03 08:00 am

    GlobeNewswire Inc.

    Read more
  • Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight

    03/02 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement

    03/01 12:30 am

    The Motley Fool

    Read more
  • A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

    02/27 03:52 pm

    GlobeNewswire Inc.

    Read more
  • One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data

    02/27 01:31 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients

    02/26 03:26 pm

    Benzinga

    Read more
  • Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

    02/25 01:54 pm

    GlobeNewswire Inc.

    Read more
  • Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors

    02/24 09:00 am

    GlobeNewswire Inc.

    Read more
  • Bristol-Myers Touts Promising Data From Blood Disorder Study

    02/23 02:43 pm

    Benzinga

    Read more
  • Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma

    02/19 09:00 am

    GlobeNewswire Inc.

    Read more
  • CTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

    02/18 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Checkpoint Inhibitors Competitive Landscape Report 2026: Comprehensive Insights About 50+ Companies and 60+ Drugs

    02/18 11:49 am

    GlobeNewswire Inc.

    Read more
  • Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight

    02/09 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Flags Data-Rich 2026 After Solid Quarter

    02/05 11:07 am

    Benzinga

    Read more
  • What's Going On With Bristol-Myers Squibb Stock Today?

    02/04 02:40 pm

    Benzinga

    Read more
  • CytomX Therapeutics to Present at Upcoming February Conferences

    02/04 09:00 am

    GlobeNewswire Inc.

    Read more
  • Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

    02/03 02:56 am

    GlobeNewswire Inc.

    Read more
  • Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

    01/27 02:43 pm

    GlobeNewswire Inc.

    Read more
  • 1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income

    01/24 08:30 pm

    The Motley Fool

    Read more
  • Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

    01/22 03:02 pm

    Benzinga

    Read more
  • The Best Stocks to Invest $1,000 in Right Now

    01/21 12:45 pm

    The Motley Fool

    Read more
  • High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

    01/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

    01/21 10:43 am

    Investing.com

    Read more
  • U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

    01/21 05:52 am

    GlobeNewswire Inc.

    Read more
  • Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool

    01/20 02:02 pm

    Benzinga

    Read more
  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs

    01/07 02:45 pm

    Benzinga

    Read more
  • 2 Dividend ETFs to Buy With $500 and Hold Forever

    01/07 08:30 am

    The Motley Fool

    Read more
  • Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

    01/07 06:00 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial

    01/06 07:43 am

    Benzinga

    Read more
  • 1 Top ETF I Plan to Load Up on in 2026

    01/02 09:05 am

    The Motley Fool

    Read more
  • Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever

    12/30 10:15 am

    The Motley Fool

    Read more
  • 3 Drug Stocks to Buy at a Discount

    12/27 05:28 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: